Cart
sales@molnova.com
Camostat mesilate
CAS No. 59721-29-8
Camostat mesilate( Foipan | FOY 305 )
Catalog No. M15218 CAS No. 59721-29-8
Camostat is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trpsin, prostasin and matriptase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 39 | In Stock |
|
| 25MG | 59 | In Stock |
|
| 50MG | 80 | In Stock |
|
| 100MG | 113 | In Stock |
|
| 200MG | 167 | In Stock |
|
| 500MG | 282 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCamostat mesilate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCamostat is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trpsin, prostasin and matriptase.
-
DescriptionCamostat is a trypsin-like protease inhibitor, inhibits airway epithelial sodium channel (ENaC) function with IC50 of 50 nM, less potent to trpsin, prostasin and matriptase.
-
In Vitro——
-
In VivoAnimal Model:6-8 week old female BALB/c mice (lethal SARS-CoV infection model)Dosage:30 mg/kg Administration:P.o.; twice a day for 9 days Result:Effective in protecting mice against death due to a lethal infection by SARS-CoV, with a survival rate of ～60%.
-
SynonymsFoipan | FOY 305
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
Recptorepithelial sodium channel (ENaC)
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number59721-29-8
-
Formula Weight494.52
-
Molecular FormulaC21H26N4O8S
-
Purity>98% (HPLC)
-
SolubilityWater: 10 mg/mL (20.22 mM); DMSO: 99 mg/mL (200.19 mM)
-
SMILESCS(O)(=O)=O.CN(C)C(=O)COC(=O)CC1=CC=C(OC(=O)C2=CC=C(C=C2)N=C(N)N)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Coote K, et al. J Pharmacol Exp Ther, 2009, 329(2), 764-774.
molnova catalog
related products
-
NHE3-IN-1
NHE3-IN-1 is a inhibitor of Na+/H+-exchanger 3 (NHE-3).
-
Ranolazine dihydroch...
An anti-ischemic agent that has been shown to inhibit late I(Na) and I(Kr) and to have antiarrhythmic effects in various preclinical in vitro models.
-
Nefopam hydrochlorid...
Nefopam hydrochloride is a centrally-acting but non-opioid analgesic drug by blocking voltage-gated sodium channel and inhibition of serotonin, dopamine and noradrenaline reuptake.
